Hypertrophic Cardiomyopathy With Elongated Mitral Valve Leaflets: Clinical Characteristics and Surgical Results

被引:0
|
作者
Liu, Xianying [1 ]
Mcgrath, Daniel [2 ]
Ohlrich, Kelly [3 ]
Chen, Frederick Y. [4 ]
Lee, Lawrence S. [4 ]
Robich, Michael [5 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Anesthesiol, Portland, OR USA
[2] Columbia Univ, Stamford Hosp, Dept Surg, Stamford, CT USA
[3] Med Univ South Carolina, Dept Cardiothorac Surg, Charleston, SC USA
[4] Tufts Med Ctr, Dept Cardiac Surg, Boston, MA USA
[5] John Hopkins Med, Div Cardiac Surg, Baltimore, MD 21224 USA
关键词
elongated mitral valve leaflets; hypertrophic cardiomyopathy; mitral valve plication; septal myectomy; MYECTOMY;
D O I
10.1155/2024/7078246
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hypertrophic cardiomyopathy (HCM) is commonly associated with mitral valve pathology. A large majority of patients with HCM have elongated anterior and posterior mitral leaflets. There remains debate regarding the necessity and role of concomitant mitral valve surgery at the time of septal myectomy. We aimed to describe the characteristics and share our surgical experiences with this specific group of patients.Methods: This retrospective single-center study investigates adult patients with HCM, with or without elongated mitral valve leaflets (MVLs), who underwent elective septal myectomy with or without concomitant mitral valve intervention, between January 1, 2016, and June 30, 2020. Clinical data were obtained from institutional medical records as well as the Society of Thoracic Surgeons data registry. The clinical characteristics and in-hospital surgical outcomes were compared between patients with an elongated MVL and those without.Results: In total, 379 patients underwent septal myectomy, and 22 patients with intrinsic mitral valve disease were excluded. In addition, 23 patients were excluded due to missing data. Of the remaining 334 patients, 131 (39.2%) had elongated MVL and concomitant MVL plication. Patients with elongated MVL had higher rates of preoperative mitral valve systolic anterior motion (SAM) (94.7% vs. 86.7%, p=0.019) and higher preoperative provoked left ventricular outflow tract gradient (LVOTG) (134.5 mmHg versus 125.3 mmHg, p=0.046). Post septal myectomy and mitral valve plication, they had lower rates of postoperative residual mitral regurgitation (3.8% vs. 12.8%, p=0.006), comparable rates of residual SAM (28.2% vs. 31.5%, p = 0.524), postoperative provoked LVOTG (15.4 mmHg vs. 14.0 mmHg, p=0.317), 30-day major adverse cardiopulmonary events (2.3% vs. 3.9%, p=0.409), and mortality (0% vs. 1.0%, p=0.255).Conclusions: Elongated MVLs contribute more significantly to dynamic LVOT obstruction, as evidenced during provocative testing. Concomitant mitral valve intervention during septal myectomy can be performed safely and may provide an effective strategy to resolve SAM and stress-induced LVOTG.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Triple Trouble of the Mitral Valve in a Patient with Hypertrophic Cardiomyopathy
    Ozden, Ozge
    Goktekin, Sule
    Tokdil, Kardelen Ohtaroglu
    Bingol, Gulsum
    Okay, Tugrul
    BALKAN MEDICAL JOURNAL, 2022, 39 (06) : 444 - 445
  • [32] Mitral Valve Disease in Hypertrophic Cardiomyopathy:Evaluation and Management
    Jain, C. Charles
    Newman, Darrell B.
    Geske, Jeffrey B.
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (11)
  • [33] Hypertrophic obstructive cardiomyopathy: the mitral valve could be the key
    Dulguerov, Filip
    Marcacci, Cecilia
    Alexandrescu, Clara
    Chan, K. M. John
    Dreyfus, Gilles D.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2016, 50 (01) : 61 - 65
  • [34] MITRAL-VALVE PROLAPSE AND HYPERTROPHIC CARDIOMYOPATHY IN A PUP
    SWINDLE, MM
    HUBER, AC
    KAN, JS
    STARR, FL
    SAMPHILIPO, MA
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1984, 184 (12) : 1515 - 1517
  • [35] Hypertrophic obstructive cardiomyopathy with abnormalities of the mitral valve complex
    Ohkado, A
    Kitamura, M
    Hachida, M
    Nishinaka, T
    Hanayama, N
    Sato, W
    Koyanagi, H
    JOURNAL OF HEART VALVE DISEASE, 1997, 6 (01): : 60 - 62
  • [36] The Mitral Valve in Obstructive Hypertrophic Cardiomyopathy A Test in Context
    Sherrid, Mark V.
    Balaram, Sandhya
    Kim, Bette
    Axel, Leon
    Swistel, Daniel G.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (15) : 1846 - 1858
  • [37] PHYSIOPATHOLOGY OF MITRAL-VALVE MECHANICS IN HYPERTROPHIC CARDIOMYOPATHY
    HAGEGE, A
    DESNOS, M
    KOMAJDA, M
    DUBOURG, O
    ISNARD, R
    GUICHENEY, P
    SCHWARTZ, K
    LEVINE, RA
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1994, 87 (10): : 1345 - 1352
  • [38] Diversity of Mitral Valve Abnormalities in Obstructive Hypertrophic Cardiomyopathy
    Cavalcante, Joao L.
    Barboza, Joaquim S.
    Lever, Harry M.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 54 (06) : 517 - 522
  • [39] Mitral valve remodeling in the development of obstructive hypertrophic cardiomyopathy
    Moroni, Francesco
    Chaturvedi, Abhishek
    Jafree, Ehsan
    Gertz, Zachary M.
    INDIAN HEART JOURNAL, 2023, 75 (04) : 308 - 310
  • [40] MITRAL-VALVE PROLAPSE AND HYPERTROPHIC CARDIOMYOPATHY IN A ROTTWEILER
    SWINDLE, MM
    HUBER, AC
    KAN, JS
    STARR, FL
    SAMPHILIPO, MA
    LABORATORY ANIMAL SCIENCE, 1982, 32 (04): : 429 - 429